PhaseOne is uniquely formulated with NovaBay Prescribed drugs’ distinctive and proprietary hypochlorous acid
NASHVILLE, Tenn. & EMERYVILLE, Calif., January 17, 2023–(BUSINESS WIRE)–PhaseOne Well being pronounces the growth of its business program for PhaseOne Pores and skin and Wound Care Cleanser by collaborative partnerships with revolutionary wound dressing producers and key wound and burn care specialists in the USA. PhaseOne is formulated with NovaBay Prescribed drugs’ (NYSE American: NBY) patented, secure hypochlorous acid.
“We anticipate wound care to be a bigger a part of our enterprise in 2023 and we’re excited to associate with PhaseOne Well being to develop our gross sales within the coming 12 months,” mentioned Justin Corridor, CEO of NovaBay Prescribed drugs.
Kris Perkins, Managing Director of PhaseOne Well being, additional defined, “We’re constructing on triple-digit proportion development over the previous couple of years by aligning with key opinion leaders and advisors to develop our business applications in 2023. Combining our previous business success with latest leads to new scientific purposes positions us effectively to pursue synergistic enterprise and protocol growth with different corporations and suppliers to handle massive market alternatives not solely in wound care however in different surgical purposes as effectively.”
PhaseOne is pure hypochlorous acid (HOCI), part of the physique’s pure immune system. HOCl is broadly referred to as protected and efficient for managing biofilm, micro organism, and fungi to advertise the therapeutic course of. Naturally produced by the physique’s white blood cells, HOCl was first synthesized by French scientist Antoine Jerome Balard in 1834 nonetheless its use in scientific purposes has expanded drastically throughout the previous 10 years. Whereas PhaseOne is primarily used for pre- and post-plastic surgical procedure procedures, this coming 12 months will convey an elevated focus within the wound care market.
PhaseOne differentiates itself within the wound care market by using NovaBay’s distinctive formulation of HOCI. Via its proprietary manufacturing course of and amber glass bottle, NovaBay ensures the most secure, purest, strongest HOCl wound cleanser in the marketplace. Its effectiveness is independently documented within the research Comparative Antimicrobial Exercise of Business Wound Care Options on Bacterial and Fungal Biofilms (Harriott, PhD et al) revealed within the peer-reviewed journal Annals of Plastic Surgical procedure.
“The Comparative Antimicrobial Exercise research is exclusive and compelling due to the massive variety of bacterial species evaluated. Much more important is the massive variety of bacterial and fungal strains evaluated inside every of those teams. This research documented the efficacy of HOCI usually for penetrating biofilm and killing quite a few gram-negative and gram-positive micro organism in addition to fungi. It additionally confirmed that when hypochlorous acid is saved in UV-resistant glass, equivalent to Section One, in comparison with plastic, there’s a development for quicker motion in penetrating biofilm and killing related organisms. When dealing both with a surgical pocket or a wound, purity and pace of motion usually tend to profit the scientific scenario,” mentioned Jack Fisher, MD, Chief Medical Officer of PhaseOne Well being. “As a consequence of PhaseOne Well being’s latest successes within the wound care market, we shall be seeking to develop our efforts.”
Mr. Perkins added, “This 12 months we’re excited to deal with partnering with organizations dedicated to offering extra environment friendly, cost-effective therapeutic options and therapies for wound and burn sufferers. We may also proceed supporting impartial research that additional discover utilization of PhaseOne in different specializations like girls’s well being. We’re wanting ahead to seeing PhaseOne Well being proceed to influence the wound care market and assist to heal these in want.”
About PhaseOne Well being and HOCl:
PhaseOne Well being hypochlorous acid safely penetrates biofilm. Biofilm represents a major barrier to wound therapeutic. PhaseOne (HOCl) resolution is efficient at penetrating biofilm and mitigating its issues. PhaseOne is a broad spectrum non-toxic and non-irritating resolution and doesn’t result in anti-microbial resistance.
Primarily based in Nashville, TN, PhaseOne Well being licenses, markets and distributes PhaseOne, a registered trademark of NovaBay Prescribed drugs, Inc.
About NovaBay Prescribed drugs, Inc.:
NovaBay Prescribed drugs, Inc. develops and sells scientifically created and clinically confirmed eyecare and skincare merchandise. NovaBay’s main product, Avenova® Antimicrobial Lid & Lash Answer, is commonly prescribed by eyecare professionals for blepharitis and dry-eye illness and can also be obtainable on to eyecare shoppers by on-line distribution channels equivalent to Amazon. DERMAdoctor® provides greater than 30 OTC dermatologist-developed skincare merchandise by the DERMAdoctor web site, well-known conventional and digital magnificence retailers, and worldwide distributors. NovaBay additionally manufactures and sells efficient, but light and non-irritating wound care merchandise. The PhaseOne® model is distributed by business companions within the U.S. for skilled use solely, and the NeutroPhase® model is distributed in China by Pioneer Pharma (Hong Kong) Firm Ltd.
NovaBay Prescribed drugs Ahead-Wanting Statements
Aside from historic data herein, issues set forth on this press launch could also be ahead wanting throughout the which means of the “protected harbor” provisions of the Personal Securities Litigation Reform Act of 1995, together with statements in regards to the business progress and future monetary efficiency of NovaBay Prescribed drugs, Inc. This launch incorporates forward-looking statements which can be based mostly upon administration’s present expectations, assumptions, estimates, projections and beliefs. These statements embrace, however usually are not restricted to, statements concerning our enterprise methods, present partnerships, advertising and marketing efforts, and any future income that will end result from such partnerships and associated advertising and marketing initiatives, in addition to usually the Firm’s anticipated future monetary outcomes. These statements contain recognized and unknown dangers, uncertainties and different elements that will trigger precise outcomes or achievements to be materially completely different and hostile from these expressed in or implied by the forward-looking statements. Elements that may trigger or contribute to such variations embrace, however usually are not restricted to, dangers and uncertainties regarding the dimensions of the potential marketplace for our merchandise, the likelihood that the obtainable marketplace for the Firm’s merchandise is not going to be as massive as anticipated, the Firm’s merchandise won’t be able to penetrate a number of focused markets, and revenues is not going to be ample to satisfy the Firm’s money wants. Different dangers regarding NovaBay’s enterprise, together with dangers that might trigger outcomes to vary materially from these projected within the forward-looking statements on this press launch, are detailed in NovaBay’s newest Type 10-Q/Okay filings and Registration Assertion on Type S-1 submitting with the Securities and Alternate Fee, particularly beneath the heading “Threat Elements.” The forward-looking statements on this launch converse solely as of this date, and NovaBay disclaims any intent or obligation to revise or replace publicly any forward-looking assertion besides as required by legislation.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20230117005165/en/
Contacts
PhaseOne Well being: information@phaseonehealth.com
NovaBay Prescribed drugs: information@novabay.com
Buyers: jcain@lhai.com
Jody Cain
LHA Investor Relations
310-691-7100
